195 related articles for article (PubMed ID: 24045788)
1. Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice.
Moise L; Tassone R; Latimer H; Terry F; Levitz L; Haran JP; Ross TM; Boyle CM; Martin WD; De Groot AS
Hum Vaccin Immunother; 2013 Oct; 9(10):2060-8. PubMed ID: 24045788
[TBL] [Abstract][Full Text] [Related]
2. Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.
Moise L; Terry F; Ardito M; Tassone R; Latimer H; Boyle C; Martin WD; De Groot AS
Hum Vaccin Immunother; 2013 Jul; 9(7):1598-607. PubMed ID: 23846304
[TBL] [Abstract][Full Text] [Related]
3. Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.
Alam S; Sant AJ
J Virol; 2011 Dec; 85(24):13310-21. PubMed ID: 21976658
[TBL] [Abstract][Full Text] [Related]
4. Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus.
Schanen BC; De Groot AS; Moise L; Ardito M; McClaine E; Martin W; Wittman V; Warren WL; Drake DR
Vaccine; 2011 Apr; 29(17):3299-309. PubMed ID: 21349362
[TBL] [Abstract][Full Text] [Related]
5. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine.
De Groot AS; Ardito M; McClaine EM; Moise L; Martin WD
Vaccine; 2009 Sep; 27(42):5740-7. PubMed ID: 19660593
[TBL] [Abstract][Full Text] [Related]
6. Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.
Yang S; Niu S; Guo Z; Yuan Y; Xue K; Liu S; Jin H
Virol J; 2013 Sep; 10():291. PubMed ID: 24053449
[TBL] [Abstract][Full Text] [Related]
7. Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.
Tan PT; Heiny AT; Miotto O; Salmon J; Marques ET; Lemonnier F; August JT
PLoS One; 2010 Jan; 5(1):e8754. PubMed ID: 20090904
[TBL] [Abstract][Full Text] [Related]
8. Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine.
Chen GL; Lau YF; Lamirande EW; McCall AW; Subbarao K
Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1140-5. PubMed ID: 21199945
[TBL] [Abstract][Full Text] [Related]
9. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals.
Kelly D; Burt K; Missaghi B; Barrett L; Keynan Y; Fowke K; Grant M
BMC Immunol; 2012 Aug; 13():49. PubMed ID: 22937824
[TBL] [Abstract][Full Text] [Related]
10. T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine.
Lambe T; Spencer AJ; Mullarkey CE; Antrobus RD; Yu LM; de Whalley P; Thompson BA; Jones C; Chalk J; Kerridge S; Hill AV; Snape MD; Pollard AJ; Gilbert SC
Pediatr Infect Dis J; 2012 Jun; 31(6):e86-91. PubMed ID: 22466328
[TBL] [Abstract][Full Text] [Related]
11. A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.
Babon JA; Cruz J; Ennis FA; Yin L; Terajima M
J Virol; 2012 Sep; 86(17):9233-43. PubMed ID: 22718815
[TBL] [Abstract][Full Text] [Related]
12. Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.
Morgan SB; Hemmink JD; Porter E; Harley R; Shelton H; Aramouni M; Everett HE; Brookes SM; Bailey M; Townsend AM; Charleston B; Tchilian E
J Immunol; 2016 Jun; 196(12):5014-23. PubMed ID: 27183611
[TBL] [Abstract][Full Text] [Related]
13. A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model.
Hewitt JS; Karuppannan AK; Tan S; Gauger P; Halbur PG; Gerber PF; De Groot AS; Moise L; Opriessnig T
Vaccine; 2019 Jul; 37(31):4302-4309. PubMed ID: 31248687
[TBL] [Abstract][Full Text] [Related]
14. Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.
Rosendahl Huber SK; Camps MG; Jacobi RH; Mouthaan J; van Dijken H; van Beek J; Ossendorp F; de Jonge J
PLoS One; 2015; 10(6):e0127969. PubMed ID: 26046664
[TBL] [Abstract][Full Text] [Related]
15. Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.
Richards KA; Chaves FA; Sant AJ
J Virol; 2009 Jul; 83(13):6566-77. PubMed ID: 19386707
[TBL] [Abstract][Full Text] [Related]
16. The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus.
Tan AC; Deliyannis G; Bharadwaj M; Brown LE; Zeng W; Jackson DC
Immunol Cell Biol; 2013 Jan; 91(1):96-104. PubMed ID: 23146941
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
[TBL] [Abstract][Full Text] [Related]
18. Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
Iorio AM; Bistoni O; Galdiero M; Lepri E; Camilloni B; Russano AM; Neri M; Basileo M; Spinozzi F
Vaccine; 2012 Feb; 30(9):1617-23. PubMed ID: 22245606
[TBL] [Abstract][Full Text] [Related]
19. Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model.
Ichihashi T; Yoshida R; Sugimoto C; Takada A; Kajino K
PLoS One; 2011; 6(9):e24626. PubMed ID: 21949735
[TBL] [Abstract][Full Text] [Related]
20. A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.
Hessel A; Schwendinger M; Fritz D; Coulibaly S; Holzer GW; Sabarth N; Kistner O; Wodal W; Kerschbaum A; Savidis-Dacho H; Crowe BA; Kreil TR; Barrett PN; Falkner FG
PLoS One; 2010 Aug; 5(8):e12217. PubMed ID: 20808939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
